Duodenal mucosa ablation (DMA) is a novel approach to treat diabetes, consisting of endoscopic ablation of dysfunctional diabetic duodenal mucosa, which, following the healing response, is replaced by normally functioning mucosa. Two techniques, duodenal mucosal resurfacing (DMR) and recellularization via electroporation therapy (ReCET), recently showed promise in type 2 diabetes mellitus (T2DM) patients.
Endoscopic duodenal mucosa ablation: the future of diabetes treatment?
Musso, Giovanni
First
Membro del Collaboration Group
;Cassader, MaurizioMembro del Collaboration Group
;Gambino, RobertoLast
Membro del Collaboration Group
2024-01-01
Abstract
Duodenal mucosa ablation (DMA) is a novel approach to treat diabetes, consisting of endoscopic ablation of dysfunctional diabetic duodenal mucosa, which, following the healing response, is replaced by normally functioning mucosa. Two techniques, duodenal mucosal resurfacing (DMR) and recellularization via electroporation therapy (ReCET), recently showed promise in type 2 diabetes mellitus (T2DM) patients.File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
Metabolic endo text+Tables TMM.R1_clean.pdf
Accesso aperto con embargo fino al 04/04/2025
Tipo di file:
POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione
195.66 kB
Formato
Adobe PDF
|
195.66 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Endoscopic duodenal mucosa ablation_the future of diabetes treatment.pdf
Accesso riservato
Tipo di file:
PDF EDITORIALE
Dimensione
424.89 kB
Formato
Adobe PDF
|
424.89 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.